Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety of GSK Biological's H1N1 Pandemic Vaccine in Manitoba, Canada

NCT01421251 is registered in ClinicalTrials.gov with International Centre for Infectious Diseases, Canada as lead sponsor.

NCT NCT01421251
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01421251 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety of GSK Biological's H1N1 Pandemic Vaccine in Manitoba, Canada
Lead sponsor
International Centre for Infectious Diseases, Canada
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2011
Completion date
December 31, 2012
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

h1n1 influenza